Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hypoparathyroidism Post-surgical

Interventions

DRUG

Indapamide 1.5 MG SR

14 days treatment with indapamide 1.5 mg/day compared to placebo

DRUG

Placebo

14 days treatment with placebo

Trial Locations (1)

RECRUITING

Department of Endocrinology and Internal Medicine, Aarhus

All Listed Sponsors

lead

Lars Rejnmark

OTHER

NCT07034677 - Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism | Biotech Hunter | Biotech Hunter